As we gear up for #RareDiseaseDay 2025, let us unite in recognizing the strength and resilience of approximately 300 million individuals worldwide living with a #RareDisease. At UCB, we are committed to amplifying patient and caregiver voices and fostering collaboration to drive meaningful change. By listening to the insights of people living with a rare disease we can enhance our drug development process, from clinical trials to regulatory discussions, and help ensure better outcomes. Collaboration is key and we call on the scientific community, regulators, payers, and industry leaders to join us in building partnerships that reflect the needs of the rare disease community. Read more from our Global Asset Head of Neuroimmunology and Rare Disease, Manuela Maronati, about how we are partnering with the community #RDD2025
About us
UCB – Inspired by patients. Driven by science. At UCB, we put our heart, soul and skills into making a difference for people living with severe diseases. We look to transform patients’ lives by pushing the boundaries of what is possible. With us, our talents makes the most of who they are, unlocking innovation and setting new standards for patients. Everything we do starts with a simple question: “How will this make a difference to the lives of people living with severe diseases?” And to find the answers, we connect globally with patients and their families living with the physical and social burdens of severe disease. These connections give us new perspectives, drive our innovation, and offer a hope for a new generation of therapies that will help to transform lives. UCB – The Facts With approximately 9000 employees in around 40 countries, we are a global biopharmaceutical company headquartered in Brussels, Belgium which invests more than 25% of revenue in cutting-edge scientific research to meet unmet patient needs. A few other reasons that make UCB an amazing place to work: - Promising pipeline that includes several novel molecules; - 2023 Key Financials: € 5.3 billion global revenue Specialties: Neurology, Immunology
- Website
-
http://www.ucb.com
External link for UCB
- Industry
- Pharmaceutical Manufacturing
- Company size
- 5,001-10,000 employees
- Headquarters
- Brussels
- Type
- Privately Held
- Founded
- 1928
- Specialties
- Neurology, Immunology, and Healthcare Innovation Beyond Medicine
Locations
Employees at UCB
Updates
-
Creating value. It’s in our culture. Be part of our Biomanufacturing community of bright-minded individuals, united by a shared purpose – enabling people with severe diseases to live the best life they can. It will be stimulating, exciting and challenging, but our culture of collaboration, care and empowerment will support you and bring out the best in you. Join us. Advance Life. Learn more https://lnkd.in/eAY8YZKe
-
-
Navigating life with a #RareDisease such as MOGAD can be challenging due to limited awareness and understanding of the condition, which can often lead to a long diagnostic pathway or misdiagnosis. Hear from our Global Patient Engagement Lead, Rare Disease, Danielle Hartigh, delve into how we can bring equity for people living with MOGAD through community partnerships and collaboration. Elevating the voices of people living with rare disease is essential to enhancing awareness and education of conditions like #MOGAD. This way, we can improve early testing and diagnosis, paving the way for better outcomes for those who need it most. #RareDiseaseDay #UCBVoices
-
We have been officially recognized with an A- rating for both climate change and water security from the renowned CDP. 💧 🌿 These high scores reflect our ongoing efforts to measuring our impact as the basis to implement actions and drive true transformational change. CDP scores play a critical role in moving companies from transparency to action. At UCB, that’s our belief too. Our commitment towards a sustainable future is stronger than ever and we hope that more companies will join us on our #EnvironmentalSustainability journey. 🤝 Learn more about our net-zero ambition 👉 https://lnkd.in/erEVTK6T and stay tuned for the release of our Integrated Annual Report to know more about our progress and actions. #NetZero #Leadership #Sustainability #TeamUCB
-
-
⭐Hidradenitis Suppurativa (HS): Did you know?⭐ Beyond the visible symptoms of #HidradenitisSuppurativa, such as lumps and abscesses, those living with this condition also experience stigma. This can impact mental well-being which has wide-reaching effects on all areas of life - including relationships, education, and careers. At UCB, we know that not all battles are visible. We stand united with the HS community in our mission to raise awareness. Together, we can make a difference. #HSAwareness #LivingwithHS
-
-
Pushing boundaries is about more than innovation. It's about the people whose lives we change. As a Field Reimbursement Executive in US Immunology, Joshua shows how innovative thinking and dedication can break down barriers, ensuring our solutions reach those who need them most. Watch his story to discover how we're going beyond to make a meaningful difference. #MakeYourMarkForPatients #TeamUCB #PharmaJobs Learn more at UCB Careers https://lnkd.in/dHkyid5y
-
As we continue to celebrate the International Day of Women and Girls in Science, we are showcasing some of our women colleagues who chose an education and career path in STEM. Hear their stories and celebrate the power of women in science! This Day is a reminder that women and girls can shape and lead scientific disciplines. Join us as we spread the word on the need to include more women and girls in STEM fields. Anne Valade Emma Lane Brittany Vallette Barbara Bovy Lissiah Hundley #WomenInScience #workinginSTEM #InternationalDayofWomenandGirlsinScience #February11 #TeamUCB
-
✨ UCB is excited to be in Vilnius, Lithuania, for#EHSF2025, the leading global congress for advancing care in #HidradenitisSuppurativa (HS)! We look forward to connecting with the HS community, collaborating with experts, and exploring innovative approaches to help people living with HS better manage their condition. Learn more about our commitment to advancing care: https://lnkd.in/ekFB8n_N #UCB #HSAwareness #Chronicinflammation
-
🌟 Celebrating 10 Years of UCBCares® 🌟 UCBCares® proudly marks its 10th anniversary - a decade of unwavering dedication to supporting people living with severe diseases, their caregivers, and healthcare providers https://lnkd.in/eySt3N79. More than just a support center, UCBCares® serves as a vital connection between UCB, healthcare providers, and the people we are committed to helping. Operating in 37 countries, we resolve over 58,000 inquiries annually, offering real-time, localized assistance and ensuring immediate access to tailored information about UCB’s medicines and resources. This milestone reflects not only our dedication to compassionate care but also our drive to continuously shape a better future for the communities we serve. 💡 Learn more about UCBCares® here https://lnkd.in/eHKTr8tT
-
We are proud to announce that UCB’s Belgian Biotech Operations Center (BBOC) has been awarded as "Factory of the Future" at the prestigious 11th Factory of the Future Awards, organized by Agoria et Sirris | Innovation forward, in Brussels https://lnkd.in/eMKymgNn ! This award recognizes companies that have successfully transformed their operations to meet the standards of Industry 4.0, excelling in technology, automation, sustainability, and workforce development. BBOC was evaluated across seven key pillars, including advanced manufacturing, digitalization, and eco-friendly operations, making this recognition a true testament to our teams' dedication and expertise. BBOC: a vision for the future 🔹 A €300M strategic investment 🔹 State-of-the-art biotech manufacturing capabilities 🔹 A key step in UCB’s journey to sustainability 🔹 A thriving hub for innovation on our Braine-l’Alleud Campus We had the honor of celebrating this milestone and networking with industry leaders, alongside distinguished guests, including Matthias Diependaele Diependaele and Walloon Vice-President and Minister of Economy and Employment Pierre-Yves Jeholet. This achievement wouldn’t have been possible without the passion and collaboration of our teams. A huge thank you to everyone who contributed to making BBOC a true Factory of the Future! #FactoryOfTheFuture #BBOC #Innovation #Sustainability #Teamwork #Biotech #FutureReady
-